Agitation | ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children
Agitation research study
What is the primary objective of this study?
There are several recommended doses of dexmedetomidine for prevention of emergence agitation
in children. In this study, the investigators examine ED50 in prevention of emergence
agitation after tonsillectomy or adenoidectomy in children.
Who is eligible to participate?
- tonsillectomy or adenoidectomy
- recent URI
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Drug:Dexmedetomidinedexmedetomidine, 0.1ug/kg up or down
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Start Date: June 2011
Completed Date: February 2012
Phase: Phase 4
Primary Outcome: agitation
Secondary Outcome: pain
Study sponsors, principal investigator, and references
Principal Investigator: Hee-Soo Kim, M.D, PhD
Lead Sponsor: Seoul National University Hospital